Cite

    P. Coloma et al.. “Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study.” Osteoporosis international, vol. 27, no. 5, 2016, pp. 1857–1867. http://access.bl.uk/ark:/81055/vdc_100080448820.0x000165